MLND - Millendo Therapeutics Inc
Previous close
1.06
0 0%
Share volume: 0
Last Updated: Fri 25 Jun 2021 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$1.06
0.00
0.00%
Summary score
34%
Profitability
43%
Dept financing
6%
Liquidity
47%
Performance
28%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.1%
Return on assets
-14.25%
Return on sales
-12889.11%
Return on invested capital
272.15%
Total debt ratio
15.15%
Debt ratio change over timeo
-0.92%
Current Ratio
8.45%
Quick Ratio
0%
Cash Position Ratio
4.44%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-23.77%
Return on assets
-18.4%
Return on sales
0%
Return on invested capital
164.19%
Total debt ratio
22.91%
Debt ratio change over timeo
-0.85%
Current Ratio
5.48%
Quick Ratio
0%
Cash Position Ratio
4.98%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-24.1%
Return on assets
-18.56%
Return on sales
0%
Return on invested capital
151.89%
Total debt ratio
22.5%
Debt ratio change over time
-0.85%
Current Ratio
5.36%
Quick Ratio
0%
Cash Position Ratio
5.06%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-109.01%
Return on assets
-107.16%
Return on sales
-4595.62%
Return on invested capital
0.62%
Total debt ratio
-91.74%
Debt ratio change over time
-0.92%
Current Ratio
2.58%
Quick Ratio
0%
Cash Position Ratio
1.22%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MLND | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -18.1% | 0% | 0% | 29.06% |
| Return on assets | -14.25% | 0% | 0% | -9.75% |
| Return on sales | -12889.11% | 0% | 0% | -1469.44% |
| Return on invested capital | 272.15% | 0% | 0% | 47.78% |
| Profitability | 25% | 0% | 50% | 29% |
| Total debt ratio | 15.15% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.92% | 0% | 0% | 19.02% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 5.48% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.98% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 59% |
| Short-term ratios | MLND | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -23.77% | 0% | 0% | -16.12% |
| Return on assets | -18.4% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 164.19% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 15% |
| Total debt ratio | 22.91% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.85% | 0% | 0% | 0.09% |
| Dept financing | 7% | 0% | 0% | 50% |
| Current Ratio | 5.48% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.98% | 0% | 0% | 5.68% |
| Liquididy | 45% | 0% | 0% | 75% |